What Determines the Quality of Rehabilitation Clinical Practice Guidelines?: An Overview Study.

Am J Phys Med Rehabil

From the Department of Physical Medicine and Rehabilitation, Wayne State University, Detroit, Michigan (MPD, SRM); Kessler Institute for Rehabilitation, West Orange, New Jersey (IW); Department of Physical Medicine and Rehabilitation, Rutgers, New Jersey Medical School, Newark, New Jersey (IW); Department of Physical Medicine and Rehabilitation, VA North Texas Health Care System and UT Southwestern Medical Center, Dallas, Texas (TA); Educational Psychology Department, University of Texas, Austin, Texas (DD); Strauss Heath Sciences Library, University of Colorado, Aurora, Colorado (LH); and Department of Emergency Medicine, Wayne State University, Detroit, Michigan (SRM).

Published: August 2021

Objective: The aim of the study was to determine what factors determine the quality of rehabilitation clinical practice guidelines.

Design: Six databases were searched for articles that had applied the Appraisal of Guidelines for Research & Evaluation II quality assessment tool to rehabilitation clinical practice guidelines. The 573 deduplicated abstracts were independently screened by two authors, resulting in 81 articles, the full texts of which were independently screened by two authors for Appraisal of Guidelines for Research & Evaluation II application to rehabilitation clinical practice guidelines, resulting in a final selection of 40 reviews appraising 504 clinical practice guidelines. Data were extracted from these by one author and checked by a second. Data on each clinical practice guideline included the six Appraisal of Guidelines for Research & Evaluation II domain scores, as well as the two Appraisal of Guidelines for Research & Evaluation II global evaluations.

Results: All six Appraisal of Guidelines for Research & Evaluation II domain scores were statistically significant predictors of overall clinical practice guideline quality rating; D3 (rigor of development) was the strongest and D1 (scope and purpose) the weakest (overall model P < 0.001, R2 = 0.53). Five of the six domain scores were significant predictors of the clinical practice guideline use recommendation, with D3 the strongest predictor and D5 (applicability) the weakest (overall model P < 0.001, pseudo R2 = 0.53).

Conclusions: Quality of rehabilitation clinical practice guidelines may be improved by addressing key domains such as rigor of development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265547PMC
http://dx.doi.org/10.1097/PHM.0000000000001645DOI Listing

Publication Analysis

Top Keywords

clinical practice
36
rehabilitation clinical
20
appraisal guidelines
20
guidelines evaluation
20
practice guidelines
16
quality rehabilitation
12
practice guideline
12
domain scores
12
clinical
9
practice
9

Similar Publications

Background: Digital biomarkers are increasingly used in clinical decision support for various health conditions. Speech features as digital biomarkers can offer insights into underlying physiological processes due to the complexity of speech production. This process involves respiration, phonation, articulation, and resonance, all of which rely on specific motor systems for the preparation and execution of speech.

View Article and Find Full Text PDF

Importance: Enhanced breast cancer screening with magnetic resonance imaging (MRI) is recommended to women with elevated risk of breast cancer, yet uptake of screening remains unclear after genetic testing.

Objective: To evaluate uptake of MRI after genetic results disclosure and counseling.

Design, Setting, And Participants: This multicenter cohort study was conducted at the University of Southern California Norris Cancer Hospital, the Los Angeles General Medical Center, and the Stanford University Cancer Institute.

View Article and Find Full Text PDF

Importance: Cell and gene therapies are revolutionizing the treatment landscape for children and adults with rare diseases and can be life-changing for patients and their families. Successful implementation of these new therapies into clinical practice depends on their accessibility and affordability, particularly through publicly funded Medicaid agencies, which cover many children and adults with rare diseases.

Objective: To provide a framework to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access through the lens of publicly funded Medicaid programs.

View Article and Find Full Text PDF

Importance: Although 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established cross-sectional biomarker of brain metabolism in dementia with Lewy bodies (DLB), the longitudinal change in FDG-PET has not been characterized.

Objective: To investigate longitudinal FDG-PET in prodromal DLB and DLB, including a subsample with autopsy data, and report estimated sample sizes for a hypothetical clinical trial in DLB.

Design, Setting, And Participants: Longitudinal case-control study with mean (SD) follow-up of 3.

View Article and Find Full Text PDF

Background: Several health care networks have fully adopted second-generation supraglottic airway (SGA) i-gel. Real-world evidence of enhanced patient safety after such practice change is lacking. We hypothesized that the implementation of i-gel compared to the previous LMA®-Unique™ would be associated with a lower risk of airway-related safety events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!